MEDIROM Healthcare Technologies Inc.(MRM)Earnings, Financials & Key Ratios
MRM•NASDAQ
$1.19
$6M mkt cap·6.5× P/E·Price updated May 6, 2026
AboutMEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.Show more
- Revenue$8.3B+21.5%
- EBITDA$272M+295.7%
- Net Income$149M+29.3%
- EPS (Diluted)28.52+28.1%
- Gross Margin27.07%+17.8%
- EBITDA Margin3.28%+261.0%
- Operating Margin-0.22%+96.2%
- Net Margin1.79%+6.4%
- ROE21.19%-85.6%
- ROIC-0.32%+96.6%
- Debt/Equity3.33-80.3%
- Interest Coverage1.96+25.6%
MRM Key Insights
MEDIROM Healthcare Technologies Inc. (MRM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 84.1%
- ✓Strong 5Y profit CAGR of 53.7%
- ✓Strong 5Y sales CAGR of 16.3%
- ✓Trading at only 0.9x book value
- ✓Efficient asset utilization: 1.0x turnover
✗Weaknesses
- ✗High debt to equity ratio of 3.3x
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 12 (bottom 12%)
- ✗Shares diluted 13.3% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
MRM Price & Volume
MEDIROM Healthcare Technologies Inc. (MRM) stock price & volume — 10-year historical chart
Loading chart...
MRM Growth Metrics
MEDIROM Healthcare Technologies Inc. (MRM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years16.25%
3 Years15.33%
TTM15.99%
Profit CAGR
10 Years-
5 Years53.71%
3 Years-
TTM275.69%
EPS CAGR
10 Years-
5 Years47.68%
3 Years-
TTM201.3%
Return on Capital
10 Years-6.33%
5 Years-10.59%
3 Years-3.11%
Last Year-0.5%
MRM Recent Earnings
MEDIROM Healthcare Technologies Inc. (MRM) EPS & revenue vs analyst estimates — last 4 quarters
●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 5, 2026EPS
$0.05
Revenue
$4M
Est $4M
+0.0%
Q2 2025
Apr 29, 2025EPS
$0.79
Revenue
$31M
Q3 2024
Jun 30, 2024EPS
$0.74
Revenue
$22M
Q3 2024
Jun 18, 2024EPS
$0.62
Revenue
$26M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.05 | $4Mvs $4M+0.0% |
| Q2 2025 | Apr 29, 2025 | $0.79 | $31M |
| Q3 2024 | Jun 30, 2024 | $0.74 | $22M |
| Q3 2024 | Jun 18, 2024 | $0.62 | $26M |
Based on last 12 quarters of dataView full earnings history →
MRM Peer Comparison
MEDIROM Healthcare Technologies Inc. (MRM) competitors in Health, Fitness and Wellness Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 XPOF | 247.38M | 6.63 | -4.51 | -1.71% | -11.08% | |||
 PLNT | 5.31B | 63.96 | 31.98 | 10.3% | 15.97% | |||
 MNMD | 2.04B | 20.69 | -10.04 | -55.3% | ||||
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 | |
 ACMR | 3.67B | 55.38 | 40.42 | 15.24% | 10.44% | 6.11% | 0.16 | |
 PTON | 2.21B | 5.20 | -17.33 | -7.77% | -2.09% | |||
 GDRX | 880.73M | 2.57 | 30.13 | 0.57% | 3.74% | 4.75% | 0.10 | |
 TDOC | 1.23B | 6.80 | -5.96 | -1.54% | -6.81% | -12.37% | 0.75 |
Compare MRM vs Peers
MEDIROM Healthcare Technologies Inc. (MRM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MRM Income Statement
MEDIROM Healthcare Technologies Inc. (MRM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 3.43B | 3.91B | 3.34B | 5.41B | 6.95B | 6.83B | 8.3B | 11.91B |
| Revenue Growth % | - | 13.84% | -14.5% | 61.89% | 28.54% | -1.81% | 21.55% | 15.99% |
| Cost of Goods Sold | 2.48B | 2.96B | 2.91B | 3.99B | 5.05B | 5.26B | 6.05B | 8.77B |
| COGS % of Revenue | 72.13% | 75.67% | 87.16% | 73.84% | 72.64% | 77.02% | 72.93% | - |
| Gross Profit | 956.87M▲ 0% | 950.76M▼ 0.6% | 428.95M▼ 54.9% | 1.42B▲ 230.0% | 1.9B▲ 34.4% | 1.57B▼ 17.5% | 2.25B▲ 43.2% | 3.14B▲ 0% |
| Gross Margin % | 27.87% | 24.33% | 12.84% | 26.16% | 27.36% | 22.98% | 27.07% | 26.36% |
| Gross Profit Growth % | - | -0.64% | -54.88% | 229.97% | 34.41% | -17.53% | 43.18% | - |
| Operating Expenses | 850.61M | 905.21M | 1.18B | 1.89B | 1.81B | 1.96B | 2.26B | 3.24B |
| OpEx % of Revenue | 24.78% | 23.16% | 35.16% | 34.86% | 25.96% | 28.71% | 27.28% | - |
| Selling, General & Admin | 842.82M | 871.86M | 1.07B | 1.81B | 1.81B | 1.96B | 2.24B | 3.22B |
| SG&A % of Revenue | 24.55% | 22.31% | 31.98% | 33.47% | 25.96% | 28.71% | 27.01% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 33.35M | 106.5M | 75.21M | 0 | 0 | 22.87M | 1000K |
| Operating Income | 114.05M▲ 0% | 78.9M▼ 30.8% | -746.09M▼ 1045.7% | -470.59M▲ 36.9% | 96.97M▲ 120.6% | -391.58M▼ 503.8% | -18.1M▲ 95.4% | -105.07M▲ 0% |
| Operating Margin % | 3.32% | 2.02% | -22.33% | -8.7% | 1.39% | -5.73% | -0.22% | -0.88% |
| Operating Income Growth % | - | -30.82% | -1045.66% | 36.93% | 120.61% | -503.83% | 95.38% | - |
| EBITDA | 158.31M | 125.07M | -683.8M | -344.34M | 281.02M | -138.98M | 271.94M | 338.42M |
| EBITDA Margin % | 4.61% | 3.2% | -20.46% | -6.37% | 4.04% | -2.04% | 3.28% | 2.84% |
| EBITDA Growth % | - | -21% | -646.73% | 49.64% | 181.61% | -149.46% | 295.66% | 77.05% |
| D&A (Non-Cash Add-back) | 44.27M | 46.17M | 62.29M | 126.24M | 184.06M | 252.59M | 290.04M | 443.48M |
| EBIT | 107.41M | 46.33M | -613.46M | -402.53M | 189.57M | 57.49M | 97.46M | 11.66M |
| Net Interest Income | -14.7M | -12.26M | -11.9M | -11.11M | -3.73M | -35.76M | -49.74M | -44.81M |
| Interest Income | 785K | 1.34M | 1.33M | 839K | 6.07M | 1.11M | 8K | -15.74M |
| Interest Expense | 15.48M | 13.59M | 13.23M | 11.95M | 9.8M | 36.87M | 49.74M | 20.8M |
| Other Income/Expense | -22.48M | -1.05M | 119.4M | 56.11M | 82.81M | 412.2M | 65.81M | 520.08M |
| Pretax Income | 91.56M▲ 0% | 33.3M▼ 63.6% | -626.69M▼ 1982.2% | -414.48M▲ 33.9% | 179.77M▲ 143.4% | 20.62M▼ 88.5% | 47.71M▲ 131.4% | 415.01M▲ 0% |
| Pretax Margin % | 2.67% | 0.85% | -18.75% | -7.66% | 2.59% | 0.3% | 0.57% | 3.49% |
| Income Tax | 25.25M | 15.96M | -87.52M | 576.25M | 30.81M | -94.43M | -90.48M | -188.64M |
| Effective Tax Rate % | 27.58% | 47.94% | 13.97% | -139.03% | 17.14% | -457.89% | -189.63% | -45.45% |
| Net Income | 66.31M▲ 0% | 17.34M▼ 73.9% | -539.17M▼ 3210.3% | -990.73M▼ 83.8% | 148.97M▲ 115.0% | 115.05M▼ 22.8% | 148.76M▲ 29.3% | 614.58M▲ 0% |
| Net Margin % | 1.93% | 0.44% | -16.13% | -18.31% | 2.14% | 1.69% | 1.79% | 5.16% |
| Net Income Growth % | - | -73.86% | -3210.3% | -83.75% | 115.04% | -22.77% | 29.3% | 275.69% |
| Net Income (Continuing) | 66.31M | 17.34M | -539.17M | -990.73M | 148.97M | 115.05M | 138.19M | 603.65M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 5.08M | 254.79M | 382.25K |
| EPS (Diluted) | 14.04▲ 0% | 4.06▼ 71.1% | -133.97▼ 3399.8% | -203.13▼ 51.6% | 27.23▲ 113.4% | 22.27▼ 18.2% | 28.52▲ 28.1% | 77.78▲ 0% |
| EPS Growth % | - | -71.08% | -3399.75% | -51.62% | 113.41% | -18.22% | 28.06% | 201.3% |
| EPS (Basic) | 18.06 | 4.63 | -133.97 | -203.13 | 30.54 | 23.64 | 29.13 | - |
| Diluted Shares Outstanding | 4.72M | 4.27M | 4.02M | 4.88M | 5.47M | 5.17M | 5.85M | 7.9M |
| Basic Shares Outstanding | 4.72M | 4.27M | 4.02M | 4.88M | 5.47M | 5.17M | 5.11M | 7.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
MRM Balance Sheet
MEDIROM Healthcare Technologies Inc. (MRM) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 934.04M | 1.38B | 2.09B | 1.38B | 2.36B | 1.76B | 2.71B | 8.4M |
| Cash & Short-Term Investments | 244.71M | 552.14M | 1.47B | 377.12M | 605.95M | 132.85M | 335.56M | 268.75K |
| Cash Only | 211.69M | 513.62M | 1.44B | 370.62M | 605.45M | 106.35M | 329.4M | 226.13K |
| Short-Term Investments | 33.02M | 38.52M | 32.52M | 6.5M | 500K | 500K | 6.16M | 42.62K |
| Accounts Receivable | 283M | 337.05M | 148.54M | 312.3M | 534.69M | 1.23B | 2B | 4.6M |
| Days Sales Outstanding | 30.09 | 31.48 | 16.22 | 21.07 | 28.06 | 65.64 | 88.04 | 29.49 |
| Inventory | 6.4M | 5.51M | 7.96M | 18.7M | 114.11M | 139.98M | 151.64M | 1.21M |
| Days Inventory Outstanding | 0.94 | 0.68 | 1 | 1.71 | 8.24 | 9.72 | 9.14 | 4.72 |
| Other Current Assets | 359.88M | 436.54M | 411.28M | 563.01M | 815.82M | 0 | 217.17M | 2.32M |
| Total Non-Current Assets | 3.59B | 3.38B | 3.63B | 4.37B | 4.38B | 5.09B | 5.38B | 46.95M |
| Property, Plant & Equipment | 2.27B | 2B | 1.81B | 2.25B | 2.38B | 2.54B | 2.51B | 15.67M |
| Fixed Asset Turnover | 1.51x | 1.96x | 1.84x | 2.41x | 2.92x | 2.69x | 3.31x | 6.41x |
| Goodwill | 63.95M | 78.28M | 150.72M | 600.33M | 539.49M | 484.56M | 389.13M | 0 |
| Intangible Assets | 76.28M | 77.64M | 97.61M | 391.04M | 403.67M | 920.7M | 1.14B | 22.16M |
| Long-Term Investments | 51.98M | 14.04M | 500K | 53.02M | 53.02M | 81.54M | 87.42M | 251.64M |
| Other Non-Current Assets | 1.12B | 1.21B | 1.56B | 1.08B | 1.01B | 961.14M | 973.46M | 2.96B |
| Total Assets | 4.52B▲ 0% | 4.76B▲ 5.2% | 5.71B▲ 20.1% | 5.75B▲ 0.7% | 6.75B▲ 17.3% | 6.85B▲ 1.5% | 8.09B▲ 18.1% | 55.36M▲ 0% |
| Asset Turnover | 0.76x | 0.82x | 0.58x | 0.94x | 1.03x | 1.00x | 1.03x | 2.29x |
| Asset Growth % | - | 5.21% | 20.09% | 0.69% | 17.28% | 1.51% | 18.13% | -83.24% |
| Total Current Liabilities | 2.35B | 2.26B | 2.65B | 3.2B | 3.64B | 3.56B | 4.18B | 34.53M |
| Accounts Payable | 141.32M | 122.59M | 67.02M | 230.9M | 207.58M | 137.7M | 1.01B | 9.82M |
| Days Payables Outstanding | 20.83 | 15.13 | 8.4 | 21.1 | 15 | 9.56 | 61.16 | 13.39 |
| Short-Term Debt | 413.74M | 371.57M | 242.28M | 162.25M | 99.17M | 500.42M | 1.11B | 14.16M |
| Deferred Revenue (Current) | 0 | 0 | 633.73M | 722.7M | 0 | 512.05M | 463.19M | 977.98M |
| Other Current Liabilities | 648.78M | 616.53M | 162.13M | 459.54M | 1.18B | 370.21M | 414.7M | 7.53M |
| Current Ratio | 0.40x | 0.61x | 0.79x | 0.43x | 0.65x | 0.49x | 0.65x | 0.65x |
| Quick Ratio | 0.39x | 0.61x | 0.78x | 0.43x | 0.62x | 0.45x | 0.61x | 0.61x |
| Cash Conversion Cycle | 10.2 | 17.03 | 8.82 | 1.68 | 21.31 | 65.8 | 36.02 | 20.82 |
| Total Non-Current Liabilities | 2.29B | 1.89B | 2.57B | 2.76B | 3.16B | 3.07B | 2.72B | 17.38M |
| Long-Term Debt | 342.77M | 150.53M | 668.38M | 746.59M | 1.15B | 1.05B | 764.2M | 4.99M |
| Capital Lease Obligations | 1.32B | 1.14B | 992.89M | 1.13B | 1.21B | 1.33B | 1.29B | 3.85B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 621.8M | 607.39M | 908.35M | 889.61M | 802.36M | 687.2M | 632.51M | 1.98B |
| Total Liabilities | 4.64B | 4.16B | 5.22B | 5.96B | 6.81B | 6.63B | 6.9B | 51.91M |
| Total Debt | 2.85B | 2.36B | 2.56B | 2.79B | 3.23B | 3.65B | 3.96B | 27.12M |
| Net Debt | 2.64B | 1.85B | 1.12B | 2.42B | 2.63B | 3.54B | 3.63B | 26.9M |
| Debt / Equity | - | 3.94x | 5.21x | - | - | 16.90x | 3.33x | 3.33x |
| Debt / EBITDA | 18.00x | 18.89x | - | - | 11.50x | - | 14.55x | 0.08x |
| Net Debt / EBITDA | 16.66x | 14.79x | - | - | 9.34x | - | 13.34x | 13.34x |
| Interest Coverage | 6.94x | 3.41x | -46.35x | -33.68x | 19.34x | 1.56x | 1.96x | 0.56x |
| Total Equity | -117.56M▲ 0% | 600.06M▲ 610.4% | 491.26M▼ 18.1% | -208.34M▼ 142.4% | -59.38M▲ 71.5% | 215.96M▲ 463.7% | 1.19B▲ 450.1% | 3.45M▲ 0% |
| Equity Growth % | - | 610.45% | -18.13% | -142.41% | 71.5% | 463.71% | 450.13% | 1026.87% |
| Book Value per Share | -24.90 | 140.45 | 122.06 | -42.72 | -10.85 | 41.80 | 203.03 | 0.44 |
| Total Shareholders' Equity | -117.56M | 600.06M | 491.26M | -208.34M | -59.38M | 210.88M | 933.27M | 3.07M |
| Common Stock | 245.1M | 595.1M | 1.18B | 1.22B | 1.22B | 20M | 352.62M | 2.44M |
| Retained Earnings | -722.64M | -705.31M | -1.7B | -2.69B | -2.55B | 80.28M | 229.04M | -3.19M |
| Treasury Stock | -3M | -3M | -3M | -3M | -3M | -3M | -3M | -20.77K |
| Accumulated OCI | -278K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 5.08M | 254.79M | 382.25K |
MRM Cash Flow Statement
MEDIROM Healthcare Technologies Inc. (MRM) cash flow — operating, investing & free cash flow history
| Line item | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 141.87M | 7.87M | -366.42M | -557.23M | -685.7M | -631.74M | -1.33B | -1.33B |
| Operating CF Margin % | 4.13% | 0.2% | -10.97% | -10.3% | -9.86% | -9.25% | -16.05% | - |
| Operating CF Growth % | - | -94.45% | -4755.91% | -52.07% | -23.05% | 7.87% | -110.8% | -2250.48% |
| Net Income | 66.31M | 17.34M | -539.17M | -990.73M | 148.97M | 115.05M | 138.19M | 614.58M |
| Depreciation & Amortization | 44.27M | 46.17M | 62.29M | 126.24M | 184.06M | 252.59M | 290.04M | 443.48M |
| Stock-Based Compensation | 149K | 0 | 0 | 196.85M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -101.64M | -188.71M | -188.71M |
| Other Non-Cash Items | 151.54M | 42.88M | -156.66M | 1.9M | -968.78M | -1.4B | -1.57B | -2.74B |
| Working Capital Changes | -120.39M | -98.52M | 267.12M | 108.5M | -49.94M | 498.76M | 1.97M | 528.34M |
| Change in Receivables | 30.17M | -66.88M | 189.14M | -37.02M | -222.38M | 580.68M | 299.96M | 969.11M |
| Change in Inventory | 6.92M | 892K | -2.44M | -2.44M | -95.41M | -25.87M | -10.61M | 43.37M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | -69.88M | 876.51M | 875.59M |
| Cash from Investing | -79.39M | -37.93M | -139.6M | -83.94M | 580.44M | -328.58M | 361.39M | -272.59M |
| Capital Expenditures | -34.3M | -7.41M | -73.56M | -95.65M | -120.74M | -135.84M | -71.41M | -152.65M |
| CapEx % of Revenue | 1% | 0.19% | 2.2% | 1.77% | 1.74% | 1.99% | 0.86% | - |
| Acquisitions | -60.27M | -3.2M | -99.19M | 54.24M | -148M | 584.77M | 887.07M | 888.46M |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 15.18M | -27.32M | 33.15M | 30.39M | 849.18M | -774.41M | -478.18M | -1.03B |
| Cash from Financing | -74.47M | 331.99M | 1.43B | -427.95M | 340.1M | 461.21M | 1.19B | 1.45B |
| Debt Issued (Net) | -254.47M | -241.91M | 388.56M | -251.08M | 502.35M | 300.92M | 324.96M | 325.59M |
| Equity Issued (Net) | 0 | 700M | 1.17B | 0 | 0 | 0 | 868.38M | 868.38M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 180M | -126.09M | -125.06M | -176.87M | -162.25M | 160.29M | 0 | 257.27M |
| Net Change in Cash | -11.99M▲ 0% | 301.93M▲ 2618.0% | 926.11M▲ 206.7% | -1.07B▼ 215.4% | 234.84M▲ 122.0% | -499.11M▼ 312.5% | 223.05M▲ 144.7% | 319.11M▲ 0% |
| Free Cash Flow | 107.57M▲ 0% | 464K▼ 99.6% | -439.98M▼ 94922.4% | -652.88M▼ 48.4% | -806.44M▼ 23.5% | -767.58M▲ 4.8% | -1.9B▼ 147.1% | -2B▲ 0% |
| FCF Margin % | 3.13% | 0.01% | -13.17% | -12.07% | -11.6% | -11.24% | -22.85% | -16.8% |
| FCF Growth % | - | -99.57% | -94922.41% | -48.39% | -23.52% | 4.82% | -147.08% | -38.82% |
| FCF per Share | 22.78 | 0.11 | -109.32 | -133.86 | -147.41 | -148.56 | -324.10 | -324.10 |
| FCF Conversion (FCF/Net Income) | 2.14x | 0.45x | 0.68x | 0.56x | -4.60x | -5.49x | -8.95x | -3.25x |
| Interest Paid | 17.01M | 11.87M | 10.22M | 10.87M | 7.54M | 34.58M | 47.56M | 33.65M |
| Taxes Paid | 14.78M | 24.34M | 7M | 45.51M | 30.81M | 52.1M | 12.78M | 12.78M |
MRM Key Ratios
MEDIROM Healthcare Technologies Inc. (MRM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 7.19% | -98.81% | -700.38% | - | 146.95% | 21.19% | 235.66% |
| Return on Invested Capital (ROIC) | 2.38% | -27.55% | -18.44% | 3.04% | -9.29% | -0.32% | -0.32% |
| Gross Margin | 24.33% | 12.84% | 26.16% | 27.36% | 22.98% | 27.07% | 26.36% |
| Net Margin | 0.44% | -16.13% | -18.31% | 2.14% | 1.69% | 1.79% | 5.16% |
| Debt / Equity | 3.94x | 5.21x | - | - | 16.90x | 3.33x | 3.33x |
| Interest Coverage | 3.41x | -46.35x | -33.68x | 19.34x | 1.56x | 1.96x | 0.56x |
| FCF Conversion | 0.45x | 0.68x | 0.56x | -4.60x | -5.49x | -8.95x | -3.25x |
| Revenue Growth | 13.84% | -14.5% | 61.89% | 28.54% | -1.81% | 21.55% | 15.99% |
MRM Frequently Asked Questions
MEDIROM Healthcare Technologies Inc. (MRM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
MEDIROM Healthcare Technologies Inc. (MRM) reported $11.91B in revenue for fiscal year 2024. This represents a 247% increase from $3.43B in 2018.
MEDIROM Healthcare Technologies Inc. (MRM) grew revenue by 21.5% over the past year. This is strong growth.
Yes, MEDIROM Healthcare Technologies Inc. (MRM) is profitable, generating $614.6M in net income for fiscal year 2024 (1.8% net margin).
Dividend & Returns
MEDIROM Healthcare Technologies Inc. (MRM) has a return on equity (ROE) of 21.2%. This is excellent, indicating efficient use of shareholder capital.
MEDIROM Healthcare Technologies Inc. (MRM) had negative free cash flow of $2.00B in fiscal year 2024, likely due to heavy capital investments.
Explore More MRM
MEDIROM Healthcare Technologies Inc. (MRM) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates